{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:19:21Z","timestamp":1779884361309,"version":"3.53.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgoncinsight.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Insight"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.soi.2025.100176","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:08:54Z","timestamp":1754582934000},"page":"100176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in surgical treatment of stage IV melanoma: A SEER database study"],"prefix":"10.1016","volume":"2","author":[{"given":"Orly N.","family":"Farber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Monton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Lilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.soi.2025.100176_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PPO.0b013e31824bc981","article-title":"Surgery for distant melanoma metastasis","volume":"18","author":"Leung","year":"2012","journal-title":"Cancer J"},{"issue":"4","key":"10.1016\/j.soi.2025.100176_bib2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/cancers15041106","article-title":"Immunotherapy in melanoma: recent advances and future directions","volume":"15","author":"Knight","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.soi.2025.100176_bib3","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/cncr.32817","article-title":"Use of immunotherapy and surgery for stage IV melanoma","volume":"126","author":"Molina","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.soi.2025.100176_bib4","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1245\/s10434-023-13543-y","article-title":"Surgical utilization and outcomes for patients with stage IV melanoma in the modern immunotherapy era","volume":"30","author":"Lwin","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soi.2025.100176_bib5","unstructured":"National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Overview of the SEER program.seer.cancer.gov\/about\/overview.html. Accessed August 7, 2025."},{"key":"10.1016\/j.soi.2025.100176_bib6","series-title":"AJCC cancer staging manual","article-title":"American joint committee on C, American cancer s","author":"Amin","year":"2022"},{"issue":"1","key":"10.1016\/j.soi.2025.100176_bib7","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Lopez Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.soi.2025.100176_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.soi.2025.100176_bib9","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.acap.2013.08.002","article-title":"Use of interrupted time series analysis in evaluating health care quality improvements","volume":"13","author":"Penfold","year":"2013","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.soi.2025.100176_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1334992","article-title":"Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database","volume":"15","author":"Xie","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.soi.2025.100176_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1039157","article-title":"The effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"issue":"19","key":"10.1016\/j.soi.2025.100176_bib12","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-14-0776","article-title":"FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation","volume":"20","author":"Kim","year":"2014","journal-title":"Clin Cancer Res"}],"container-title":["Surgical Oncology Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950247025000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950247025000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:32:26Z","timestamp":1774873946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950247025000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2950247025000623"],"URL":"https:\/\/doi.org\/10.1016\/j.soi.2025.100176","relation":{},"ISSN":["2950-2470"],"issn-type":[{"value":"2950-2470","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in surgical treatment of stage IV melanoma: A SEER database study","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soi.2025.100176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Society of Surgical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100176"}}